Deep search
All
Search
Images
Videos
Maps
News
Copilot
More
Shopping
Flights
Travel
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Politics
Order by
Best match
Most fresh
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Novo Nordisk slashes price of Ozempic
Digest more
Top News
Overview
· 1d
Novo Nordisk slashes price of Ozempic to $499 for cash-paying, uninsured patients
"Improving access to our authentic FDA-approved treatments is central to our mission at Novo Nordisk," said Novo Nordisk's executive vice president Dave Moore in a statement.
Continue reading
· 1d
Canada approves Ozempic to cut risk of kidney failure, heart-related deaths
Canada has approved Novo Nordisk's (NOVOb.CO) diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of kidney failure and heart-related deaths in type-2 diabetes patie...
Continue reading
Explícame on MSN
1d
Novo Nordisk announces significant price cut for its most coveted diabetes drug
Novo Nordisk launches a new cash-pay option for a leading diabetes drug, changing affordability dynamics for uninsured patients across the U.S.
Feedback